IP Library › Granted Patent US 8,003,681
Granted Patent B2
US 8,003,681 · App. 12/633,638 · Granted Aug 23, 2011

2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and methyl ester

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,003,681
App. No.
12/633,638
Granted
Aug 23, 2011
Kind
B2
Abstract

A series of S-triazolyl α-mercaptoacetanilides having general structure (1) are provided, where Q is CO 2 H, CONR 2 , SO 3 H, or SO 2 NR 2 . The compounds inhibit several variants of the reverse transcriptase of HIV, and are useful in the treatment of HIV infections.

Claims (2)

1. A compound having the structure:

2. A compound having the structure:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 8, 2009
From: GIRARDET, JEAN LUC; KOH, YUNG-HYO
To: ARDEA BIOSCIENCES, INC.
Reel/Frame 023623/0365 →